Homechevron_rightNewschevron_rightMedia Releasechevron_rightVaxxas Publication in PLoS Medicine Reveals Groundbreaking Clinical Research on Broad Potential of Novel High-Density Microarray Patch (HD-MAP)

Vaxxas Publication in PLoS Medicine Reveals Groundbreaking Clinical Research on Broad Potential of Novel High-Density Microarray Patch (HD-MAP)

17 March 2020

Posted in — Media Release

Share

To Effeciently Deliver Vaccines Directly to the Skin, Enhancing Immunogenicity

Read the full media release below.

Learn more

Posted in — Media Release

Share

chevron_leftPreviosly

Bill Gates backs Aussie patch-up for next pandemic

18 March 2020

Nextchevron_right

Why 20-year-old Aussie tech firm is taking on start-up style funding

16 March 2020

View All

Subscribe to our Newsletter for the latest updates from 1V.

Vaxxas Publication in PLoS Medicine Reveals Groundbreaking Clinical Research on Broad Potential of Novel High-Density Microarray Patch (HD-MAP)

Bill Gates backs Aussie patch-up for next pandemic

Why 20-year-old Aussie tech firm is taking on start-up style funding

You may also like

OneVentures Venture Credit Fund poised to invest $120M into Australian scaleups

Australian First:-Israeli venture partnership launches new Venture Credit Fund to invest in high-growth technology companies

DoseMe partners with Charm Health to improve management of high risk oncology medicines and deliver “precision medicine” to Australian cancer patients

OneVentures expands team to internationalise its healthcare portfolio

OneVentures’ Innovation and Growth Fund II hits $100 million in FUM

Citadel Group aquires OneVentures portfolio company Charm Health

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.